The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail vetinfo@hpra.ie


Cylanic 500 mg + 125 mg tablets for dogs



LIVISTO Int'l, S.L.VPA10425/017/003

Main Information

Trade NameCylanic 500 mg + 125 mg tablets for dogs
Active SubstancesAmoxicillin trihydrate
Potassium clavulanate
Dosage FormTablet
Licence HolderLIVISTO Int'l, S.L.
License Holder AddressAv. Universitat Autònoma, 29
08290 Cerdanyola del Vallès
Barcelona
Spain
Licence NumberVPA10425/017/003

Group Information

ATC CodeQJ01CR02 amoxicillin and enzyme inhibitor
Therapeutic ClassAntibacterial
SpeciesDogs

Status

License statusAuthorised
Licence Issued28/05/2021
Legal StatusPOM: Prescription Only Medicine as defined in relevant national legislation

Documents

Summary of Product Characteristics *PDF Version
Package LeafletNo document available
Public Assessment ReportPDF Version
VariationsPDF Version

* The PDF document, together with the national-specific product information on this page, constitute the authorised SPC
« Back